Chickenpox vaccines enclosed an attenuated (weakened) live strain of the varicella-zoster (chickenpox) virus. Serious diseases such as herpes zoster and chickenpox can be caused as these vaccines stimulate the immune system against the varicella-zoster virus. Varicella vaccines are of two types namely monovalent and combination varicella vaccines. Absence of chickenpox immunization can lead to complications such as bacterial infections of the skin, joints or bloodstream (sepsis), soft tissues, bones, pneumonia, encephalitis, or even cause death.
Active contribution of government in immunization programs, growing awareness on the subject of chickenpox vaccines usage, and surge in the recognition of chickenpox vaccines are the key driving factors in chickenpox vaccine market. For instance, as per the Centers for Disease Control and Prevention (CDC), in United States each year about 11,000 individuals are hospitalized due to chicken pox complications. However, time required for the development of this vaccine and high cost associated with it is limiting the usage of chickenpox vaccine.
The "Chickenpox Vaccine Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of chickenpox vaccine market with detailed market segmentation by vaccine and application. The chickenpox vaccine market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in chickenpox vaccine market and offers key trends and opportunities in the market.
The chickenpox vaccine market is segmented on the basis of vaccine and application. Based on vaccine, the market is segmented as monovalent varicella vaccine and combination varicella vaccine. By application, kids injection and adults injection is the segmentation.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the chickenpox vaccine market based onvarious segments.It also provides market size and forecast estimates from year 2020 to2028with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The chickenpox vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting chickenpox vaccine market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the chickenpox vaccine market in these regions.
Get more information on this report :
The report covers key developments in the chickenpox vaccine market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from chickenpox vaccine market are anticipated to have lucrative growth opportunities in the future with the rising demand for chickenpox vaccine in the global market. Below mentioned is the list of few companies engaged in the chickenpox vaccine market.
The report also includes the profiles of key players in chickenpox vaccine market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and vaccine and applications offered, financial information of last 3 years, key development in past five years.
MERCK AND CO. INC.
GC PHARMA (GREEN CROSS HOLDINGS)
BIO-MED PVT LTD
NOVO MEDI SCIENCES PVT LTD
TAKEDA PHARMACEUTICAL COMPANY LIMITED
MITSUBISHI TANABE PHARMA CORPORATION
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
Get more information on this report :
The List of Companies
1. GLAXOSMITHKLINE PLC
2. MERCK AND CO. INC.
3. GC PHARMA (GREEN CROSS HOLDINGS)
4. BIO-MED PVT LTD
5. NOVO MEDI SCIENCES PVT LTD
7. TAKEDA PHARMACEUTICAL COMPANY LIMITED
8. MITSUBISHI TANABE PHARMA CORPORATION